Jenburkt Pharmaceuticals Ltd
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|
| Revenue | 37.03 | 48.98 | 44.84 |
| Operating Expense | 29.49 | 34.33 | 35.59 |
| Net Profit | 5.89 | 10.85 | 5.93 |
| Net Profit Margin | 15.91% | 22.15% | 13.22% |
| Earning Per Share | 13.34 | 24.58 | 13.44 |
| EBIDTA | 7.66 | 15.43 | 9.88 |
| Effective Tax Rate | 13.26% | 24.85% | 32.47% |
Particulars
Jun 2026
Revenue37.03
Operating Expense29.49
Net Profit5.89
Net Profit Margin15.91
Earning Per Share13.34
EBIDTA7.66
Effective Tax Rate13.26
